v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Registered direct offering
Common Stock
At the market offering
Common Stock
Additional Paid-in Capital
Registered direct offering
Additional Paid-in Capital
At the market offering
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Deficit
Registered direct offering
At the market offering
Total
Beginning Balance - Shares at Mar. 31, 2023     24,685,059                
Beginning Balance - Amount at Mar. 31, 2023     $ 25     $ 55,953 $ (127) $ (4,479)     $ 51,372
Issuance of common stock under employee stock option plans, shares     482,313                
Issuance of common stock under employee stock option plans, amount           1,654         1,654
Issuance of common stock net of issuance costs, shares   133,000                  
Issuance of common stock net of issuance costs, amount         $ 153         $ 153  
Stock-based compensation expense           2,838         2,838
Net Income (Loss)               (20,087)     (20,087)
Net unrealized gain on available-for-sale investments             40       40
Ending Balance, Shares at Mar. 31, 2024     25,300,372                
Ending Balance, Amount at Mar. 31, 2024     $ 25     60,598 (87) (24,566)     35,970
Issuance of common stock under employee stock option plans, shares     305,601                
Issuance of common stock under employee stock option plans, amount     $ 1     632         633
Stock-based compensation expense           2,262         2,262
Net Income (Loss)               (10,639)     (10,639)
Ending Balance, Shares at Mar. 31, 2025     25,605,973                
Ending Balance, Amount at Mar. 31, 2025     $ 26     63,492 (87) (35,205)     28,226
Issuance of common stock under employee stock option plans, shares     1,487,717                
Issuance of common stock under employee stock option plans, amount     $ 2     6,231         6,233
Issuance of common stock net of issuance costs, shares 1,508,462 4,508,350                  
Issuance of common stock net of issuance costs, amount $ 2 $ 4   $ 4,678 $ 14,264       $ 4,680 $ 14,268  
Warrants exercised, net of offering costs, shares     3,491,538                
Warrants exercised, net of offering costs, amount     $ 3     38,794         38,797
Stock-based compensation expense           2,803         2,803
Net Income (Loss)               (13,246)     (13,246)
Ending Balance, Shares at Mar. 31, 2026     36,602,040                
Ending Balance, Amount at Mar. 31, 2026     $ 37     $ 130,262 $ (87) $ (48,451)     $ 81,761